 Genital warts, caused by low-risk human papillomaviruses, are a common sexually transmitted disease worldwide, with current treatments including ablation or topical application of imiquamod and sciencatic inointment, but low patient compliance and high recurrence rates are significant problems. Recent literature suggests combining imiquamod with other therapies to increase its efficacy. This article was authored by Jianwei Yuan, Guoying Ni, Tianfang Wang, and others.